Helix Nano

Helix Nano (HelixNano) is a Boston-based biotechnology company developing new ways to manipulate messenger RNA (mRNA) — the molecule that carries instructions from genes to the cell's protein-making machinery. Backed by DCVC since 2017, the company has developed techniques to improve the effectiveness and specificity of mRNA vaccines, including a next-generation COVID-19 vaccine engineered to resist viral mutation. HelixNano is now pursuing a broader vision of self-designing, adaptive therapeutics — drugs that could improve with every patient and, ideally, require only a single dose. The company operates out of 5 Channel Center Street in Boston, Massachusetts, and remains at an early, largely stealth stage with no public developer program or API surface at this time.

Helix Nano is profiled on the APIs.io network. Tagged areas include Company, Biotechnology, mRNA, Vaccines, and Therapeutics.

🌐 Visit website 📡 Source on GitHub

3.3/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-08-20 · rubric v0.12.0

0 APIs

CompanyBiotechnologymRNAVaccinesTherapeuticsLife SciencesDrug Discovery

Kin Score

Kin Score How this is scored →
scored 2026-08-20 · rubric v0.12.0

Composite quality — 3.3/100 · minimal

Contract Quality 0.0 / 21

Developer Ergonomics 0.0 / 17

Access Clarity 0.0 / 17

Operational Transparency 0.0 / 11

Contract Governance 0.0 / 10

Discoverability 4.3 / 9

Regulatory Posture 1.1 / 15

Agent readiness — 0/100 · human only

Machine-Readable Contract 0 / 18

Agentic Access Contract 0 / 10

Documented Reversibility 0 / 6

MCP Server 0 / 12

Machine-Readable Auth 0 / 10

Idempotency 0 / 9

Stable Error Semantics 0 / 8

Request/Response Examples 0 / 7

Rate-Limit Signaling 0 / 7

Typed Event Surface 0 / 6

Agent Skills 0 / 5

Well-Known Catalog 0 / 4

Consent & Bot Identity 0 / 3

A2A Agent Card 0 / 8

Dry-Run / Simulate Mode 0 / 4

Regulatory Posture applies to this provider. Its tags matched the Health regime, so Regulatory Posture carries 15 points of the composite. If this regime is wrong for your business, say so on your provider repo — the applicability map is public and we will correct it.

The six quality facets above are damped to 85 points between them, because the conditional facet above carries the other 15. That is why each facet's contribution is shown against a damped maximum: raising a quality facet moves the composite by 85% of its nominal weight, not 100%. The full arithmetic is at apis.io/rating/.

Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/helix-nano: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Access & Security 1

Authentication, authorization, and security posture

DomainSecurity

DomainSecurity

Company 2

The organization behind the API

Website

Website

Careers

Careers

Source (apis.yml)

aid: helix-nano
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/helix-nano.png
name: Helix Nano
description: Helix Nano (HelixNano) is a Boston-based biotechnology company developing new ways to manipulate messenger RNA
  (mRNA) — the molecule that carries instructions from genes to the cell's protein-making machinery. Backed by DCVC since
  2017, the company has developed techniques to improve the effectiveness and specificity of mRNA vaccines, including a next-generation
  COVID-19 vaccine engineered to resist viral mutation. HelixNano is now pursuing a broader vision of self-designing, adaptive
  therapeutics — drugs that could improve with every patient and, ideally, require only a single dose. The company operates
  out of 5 Channel Center Street in Boston, Massachusetts, and remains at an early, largely stealth stage with no public developer
  program or API surface at this time.
url: https://raw.githubusercontent.com/api-evangelist/helix-nano/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- dcvc
x-tier: stub
x-tier-reason: portfolio-lead
specificationVersion: '0.23'
created: '2026-07-17'
modified: '2026-07-19'
tags:
- Company
- Biotechnology
- mRNA
- Vaccines
- Therapeutics
- Life Sciences
- Drug Discovery
apis: []
common:
- type: DomainSecurity
  url: security/helix-nano-domain-security.yml
- type: Website
  url: https://www.helixnano.com
- type: Careers
  url: https://www.helixnano.com/careers
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
x-enrichment:
  date: '2026-07-19'
  status: backfilled
  pass: local-v1
  note: backfilled from .gitignore signal + verified work evidence

Helix Nano

Kin Score

Security Posture 1

Helix Nano Domain Security

Resources

Access & Security 1

Company 2

Source (apis.yml)